Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Tipo de estudio
Intervalo de año de publicación
1.
Eur J Paediatr Dent ; 24(4): 334-336, 2023 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-38015115

RESUMEN

BACKGROUND: Mandibulofacial dysostosis Guion-Almeida Type (MFDGA; OMIM#610536) is a rare autosomal dominant genetic disorder caused by heterozygous pathogenic variants in the EFTUD2 gene. Mandibulofacial dysostoses are characterised by the core triad malar hypoplasia, maxillary hypoplasia and dysplastic ears, all derived by the impaired development of the first and second branchial arches. Differential diagnosis is often challenging. The early genetic diagnosis is extremely useful, not only for the correct management of cranial malformations, but also for the early diagnosis and treatment of the comorbidities associated to the disease, which greatly benefit from early treatment.


Asunto(s)
Región Branquial , Disostosis Mandibulofacial , Humanos , Disostosis Mandibulofacial/genética , Diagnóstico Diferencial , Cigoma , Factores de Elongación de Péptidos , Ribonucleoproteína Nuclear Pequeña U5
2.
Eur J Clin Pharmacol ; 76(5): 731-732, 2020 May.
Artículo en Inglés | MEDLINE | ID: mdl-31938857

RESUMEN

Adverse drug reactions occur at a high rate in hospitalized children, frequently due to antiepileptic drug administration. Phenytoin is a commonly used drug, and its metabolism is mediated by a specific cytochrome-P450 isoform, CYP2C9, which is encoded by a polymorphic gene. It is worth noting that very frequently administered drugs, such as proton pump inhibitors, compete with phenytoin for CYP2C19-mediated metabolism. Here we describe a case of phenytoin intoxication in a child with defective CYP2C9, after omeprazole administration.


Asunto(s)
Citocromo P-450 CYP2C9/metabolismo , Omeprazol/administración & dosificación , Fenitoína/efectos adversos , Preescolar , Citocromo P-450 CYP2C19/metabolismo , Citocromo P-450 CYP2C9/genética , Interacciones Farmacológicas , Genotipo , Humanos , Fenitoína/sangre , Polimorfismo Genético
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA